State of the Market Report - Circulating Tumor Cells

State of the Market Report - Circulating Tumor Cells

We’ve used our Data Visualisation feature to show the overview of Circulating Tumor Cells (CTCs). This graphical representation of the search results provides you with an accessible way to understand trends, patterns, and outliers from the extensive SciLeads data.

To see the data for your market, click the button to set up your free trial:

tradeshows - CTC.png

In this chart which details which tradeshows Circulating Tumor Cells researchers attend, you can see that the American Association of Cancer Research (AACR) has had 1.8k researchers present.

The Data Visualisation feature provides a high-level overview of the statistics, whereas users can also click the ‘Researcher Tab’ in the platform to explore the poster talk sessions in more detail.

countries - CTC.png

As you can see, the USA has the highest number of researchers for Circulating Tumor Cells with a collective result of 3.7k with China being second with 2.4k researchers.


A deep dive into the data shows that the state of California has the most researchers with 1.1k. Texas follows with 869 and Massachusetts with 546.


Our curated data shows that the total number of funding awards granted since 2012 for Circulating Tumor Cells is 1.8k. The Data Visualisation of this information shows that the funding amount peaked in 2018 at $207.1m and dropped to $60m in 2020, most likely due to funding being diverted to COVID-19 research. The amount doubled in 2021 to $129.9m so it will be interesting to see the amount awarded in 2022.

Note - the results show in USD the total of all grants that appear in the search (other currencies are standardized to USD).

This is just some of the data available to view for this application area in the platform. If you want to run this keyword yourself and get even further insights, get set up with a demonstration and trial here.

Have a data visualization suggestion? If there are other charts and insights you think this feature could show, please send your ideas via our contact us page.